
Rong Le
Examiner (ID: 6693, Phone: (571)270-7637 , Office: P/2423 )
| Most Active Art Unit | 2421 |
| Art Unit(s) | 2423, 2421 |
| Total Applications | 494 |
| Issued Applications | 304 |
| Pending Applications | 67 |
| Abandoned Applications | 142 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9569848
[patent_doc_number] => 20140187562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'PREPARATION OF CRYSTALLINE FORMS OF DIHYDROPYRAZOLOPYRIMIDINONE'
[patent_app_type] => utility
[patent_app_number] => 14/199653
[patent_app_country] => US
[patent_app_date] => 2014-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3144
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14199653
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/199653 | Preparation of crystalline forms of dihydropyrazolopyrimidinone | Mar 5, 2014 | Issued |
Array
(
[id] => 11827706
[patent_doc_number] => 09724435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-08
[patent_title] => 'Highly selective sigma receptor ligands and radioligands as probes in nociceptive processing and the pathphysiological study of memory deficits and cognitive disorders'
[patent_app_type] => utility
[patent_app_number] => 14/196483
[patent_app_country] => US
[patent_app_date] => 2014-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 25
[patent_no_of_words] => 32383
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14196483
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/196483 | Highly selective sigma receptor ligands and radioligands as probes in nociceptive processing and the pathphysiological study of memory deficits and cognitive disorders | Mar 3, 2014 | Issued |
| 14/188072 | 11BETA-HSD1 MODULATORS | Feb 23, 2014 | Abandoned |
Array
(
[id] => 9806393
[patent_doc_number] => 20150018339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'HIGHLY SELECTIVE SIGMA RECEPTOR LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 14/187035
[patent_app_country] => US
[patent_app_date] => 2014-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10606
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14187035
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/187035 | HIGHLY SELECTIVE SIGMA RECEPTOR LIGANDS | Feb 20, 2014 | Abandoned |
Array
(
[id] => 9546848
[patent_doc_number] => 20140171496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-19
[patent_title] => 'COMPOSITION AND METHOD FOR PROMOTING HAIR GROWTH'
[patent_app_type] => utility
[patent_app_number] => 14/175356
[patent_app_country] => US
[patent_app_date] => 2014-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6646
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14175356
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/175356 | COMPOSITION AND METHOD FOR PROMOTING HAIR GROWTH | Feb 6, 2014 | Abandoned |
Array
(
[id] => 9568615
[patent_doc_number] => 20140186329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'POLYPHENOL ANALOGS TO TREAT ISCHEMIA'
[patent_app_type] => utility
[patent_app_number] => 14/174222
[patent_app_country] => US
[patent_app_date] => 2014-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 41487
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14174222
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/174222 | POLYPHENOL ANALOGS TO TREAT ISCHEMIA | Feb 5, 2014 | Abandoned |
Array
(
[id] => 11521522
[patent_doc_number] => 09604907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-28
[patent_title] => 'Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics'
[patent_app_type] => utility
[patent_app_number] => 14/165090
[patent_app_country] => US
[patent_app_date] => 2014-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 18533
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14165090
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/165090 | Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics | Jan 26, 2014 | Issued |
Array
(
[id] => 9511967
[patent_doc_number] => 20140148460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-29
[patent_title] => 'THERAPEUTIC COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/162280
[patent_app_country] => US
[patent_app_date] => 2014-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2662
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14162280
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/162280 | THERAPEUTIC COMPOSITIONS | Jan 22, 2014 | Abandoned |
Array
(
[id] => 9597844
[patent_doc_number] => 20140194526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'STABILIZED COMPOSITIONS OF VOLATILE ALKYLATING AGENTS AND METHODS OF USING THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/153914
[patent_app_country] => US
[patent_app_date] => 2014-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10892
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14153914
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/153914 | Stabilized compositions of volatile alkylating agents and methods of using thereof | Jan 12, 2014 | Issued |
Array
(
[id] => 9562207
[patent_doc_number] => 20140179921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'CHEMICAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/147694
[patent_app_country] => US
[patent_app_date] => 2014-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19320
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14147694
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/147694 | CHEMICAL COMPOUNDS | Jan 5, 2014 | Abandoned |
Array
(
[id] => 10289147
[patent_doc_number] => 20150174145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'Pharmaceutical compounds with the structure of ionic salts with antibiotic and anticancer action'
[patent_app_type] => utility
[patent_app_number] => 14/138156
[patent_app_country] => US
[patent_app_date] => 2013-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2489
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14138156
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/138156 | Pharmaceutical compounds with the structure of ionic salts with antibiotic and anticancer action | Dec 22, 2013 | Abandoned |
Array
(
[id] => 10940145
[patent_doc_number] => 20140343166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES'
[patent_app_type] => utility
[patent_app_number] => 14/094694
[patent_app_country] => US
[patent_app_date] => 2013-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22612
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14094694
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/094694 | TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES | Dec 1, 2013 | Abandoned |
Array
(
[id] => 10920497
[patent_doc_number] => 20140323516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'METHODS OF TREATING DERMATOLOGICAL DISORDERS AND INDUCING INTERFERON BIOSYNTHESIS WITH SHORTER DURATIONS OF IMIQUIMOD THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/091589
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13838
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14091589
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/091589 | Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy | Nov 26, 2013 | Issued |
Array
(
[id] => 9371040
[patent_doc_number] => 20140080913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'Sensory-Specific Local Anesthesia and Prolonged Duration Local Anesthesia'
[patent_app_type] => utility
[patent_app_number] => 14/086765
[patent_app_country] => US
[patent_app_date] => 2013-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8801
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14086765
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/086765 | Sensory-Specific Local Anesthesia and Prolonged Duration Local Anesthesia | Nov 20, 2013 | Abandoned |
Array
(
[id] => 9478066
[patent_doc_number] => 20140135529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'METHOD FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT'
[patent_app_type] => utility
[patent_app_number] => 14/081643
[patent_app_country] => US
[patent_app_date] => 2013-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15934
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14081643
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/081643 | METHOD FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT | Nov 14, 2013 | Abandoned |
Array
(
[id] => 11067553
[patent_doc_number] => 20160264517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => '3-AMINOCYCLOPENTANE CARBOXAMIDE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/442242
[patent_app_country] => US
[patent_app_date] => 2013-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27483
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442242
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/442242 | 3-aminocyclopentane carboxamide derivatives | Oct 16, 2013 | Issued |
Array
(
[id] => 9562084
[patent_doc_number] => 20140179797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'Composition for Administering an NMDA Receptor Antagonist to a Subject'
[patent_app_type] => utility
[patent_app_number] => 14/052507
[patent_app_country] => US
[patent_app_date] => 2013-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15788
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14052507
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/052507 | Composition for Administering an NMDA Receptor Antagonist to a Subject | Oct 10, 2013 | Abandoned |
Array
(
[id] => 9295425
[patent_doc_number] => 20140039059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'USE OF HISTONE DEACETYLASE INHIBITORS FOR THE CARE OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE SYNDROMES'
[patent_app_type] => utility
[patent_app_number] => 14/047391
[patent_app_country] => US
[patent_app_date] => 2013-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2363
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14047391
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/047391 | Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative syndromes | Oct 6, 2013 | Issued |
Array
(
[id] => 15006119
[patent_doc_number] => 10449164
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-22
[patent_title] => Methods of treating ocular disorders using semifluorinated alkanes
[patent_app_type] => utility
[patent_app_number] => 14/427927
[patent_app_country] => US
[patent_app_date] => 2013-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8809
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427927
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/427927 | Methods of treating ocular disorders using semifluorinated alkanes | Sep 11, 2013 | Issued |
Array
(
[id] => 9363758
[patent_doc_number] => 20140073631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'ANTIVIRAL AND ANTIMICROBIAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/022433
[patent_app_country] => US
[patent_app_date] => 2013-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 22102
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14022433
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/022433 | ANTIVIRAL AND ANTIMICROBIAL COMPOUNDS | Sep 9, 2013 | Abandoned |